Old Web
English
Sign In
Acemap
>
authorDetail
>
Claudia Gonzalo-Consuegra
Claudia Gonzalo-Consuegra
Complutense University of Madrid
Amyotrophic lateral sclerosis
Cannabinoid
Neuroprotection
Cannabinoid receptor type 2
Medicine
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis
2021
British Journal of Pharmacology
Carmen Rodríguez-Cueto
Laura García-Toscano
Irene Santos-García
Marta Gómez-Almería
Claudia Gonzalo-Consuegra
Francisco Espejo-Porras
Javier Fernández-Ruiz
Eva de Lago
Show All
Source
Cite
Save
Citations (3)
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.
2021
International Journal of Molecular Sciences
Loreto Martínez-González
Claudia Gonzalo-Consuegra
Marta Gómez-Almería
Gracia Porras
Eva de Lago
Ángeles Martín-Requero
Ana Martinez
Show All
Source
Cite
Save
Citations (0)
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson’s disease using 6-hydroxydopamine-lesioned mice
2020
Molecular and Cellular Neuroscience
Sonia Burgaz
Concepción García
María Gómez-Cañas
Carmen Navarrete
Adela García-Martín
Alain Rolland
Carmen del Río
M. J. Casarejos
Eva Muñoz
Claudia Gonzalo-Consuegra
Eduardo Muñoz
Javier Fernández-Ruiz
Show All
Source
Cite
Save
Citations (4)
Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis.
2020
European Journal of Medicinal Chemistry
Elisa Rojas-Prats
Loreto Martínez-González
Claudia Gonzalo-Consuegra
Nicole F. Liachko
Concepción Pérez
David Ramirez
Brian C. Kraemer
Ángeles Martín-Requero
Daniel I. Perez
Carmen Gil
Eva de Lago
Ana Martínez
Show All
Source
Cite
Save
Citations (6)
1